The United States spends almost twice as much per capita on healthcare versus other developed countries. This level of expenditure is driving disruption -- which is occurring on many fronts, including reformation of retail pharmacy models. While COVID-19 created a catalyst for change, and clearly demonstrated the importance that retail pharmacies play in the healthcare ecosystem, the long-term viability of traditional models continues to be challenged.